Carnosic acid sales will strengthen through 2036, anchored by rosemary extract at 61.8% of the source segment in 2026. The market was valued at USD 310.2 million in 2025 and is expected to be worth USD 487.7 million by 2036, creating an incremental opportunity of USD 164.5 million.